Overall verdict
Neutral
4.2/10
1-year performance
+11.95%
Score breakdown
Up 11.9% over 1 year, 85% of the 52-week range.
Strongest: Profitability 7.8/10. Weakest: Growth 0.6/10.
15 analysts, target -0.1% vs the price.
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT insurance products, as well as WAYS and child endowment, and Tsumitasu insurance products in Japan. Its Aflac U.S. segment provides accident, disability, cancer, critical illness, hospital indemnity, dental, vision, and life insurance products in the United States.
The company also provides hearing, final expense, pet, Medicare supplement, supplemental dental and vision, short-term disability, and absence management insurance products, as well as cafeteria plans. It sells its products to individuals, families, and business owners through individual, independent corporate, and affiliated corporate agencies; banks; independent associates/career agents; and brokers. Aflac Incorporated was founded in 1955 and is headquartered in Columbus, Georgia.
Sector
Financials
Industry
Insurance
Primary listing
Nyse
United States
CEO
Daniel Amos
Founded
1955
Employees
12 716
Revenue / employee
1.3M USD
Next earnings
February 3, 2027 (estimated)
Institutional holders
- GEODE CAPITAL MANAGEMENT, LLC2.11%
- Bank of New York Mellon Corp0.50%
- FMR LLC0.38%
- Rest of the register97.01%
3 13F filings as of September 30, 2026: US managers above $100M, filed up to 45 days after quarter end. No insiders, no retail. A share on loan is declared by its lender and by whoever bought it from the short seller, so the total can exceed 100%.
Research uses the underlying stock’s market history. The purchase quote is calculated separately when you review your order.
52-week high
131.19 USD
52-week low
105.76 USD
1-year performance
11.95%
Rising
Year-to-date performance
15.63%
Rising
Drawdown
-2.92%
Near its high
Position in the 52-week range
85% of range
Against the world ETF
Over 26 years, from December 2000 to October 2026, the share did not clearly beat the world ETF once risk is accounted for. It earned much more, but shaking 1.9 times harder: once that risk is counted, it did about as well as the ETF.
$10,000 placed at the end of December 2000 are worth today
| Aflac | $116,230 |
| World ETF | $65,117 |
| S&P 500 | $91,204 |
| Risk-free placement | $15,894 |
The risk
- Shaking:the share moves 1.9 times as much as the world ETF.
- Worst fall:-74 % between May 2008 and February 2009. $10,000 placed at the top fell to $2,554. The world ETF, at worst: -53 %. Back to its high in 53 months.
Aflac earned more than the world ETF since 2000
Value of $10,000 placed at the end of December 2000, dividends reinvested, in dollars
- Aflac: $116,230
- World ETF: $65,117
- S&P 500: $91,204
- Risk-free placement: $15,894
Based on past performance. This is not a recommendation.
Range: 101.00 USD - 143.00 USD (2 methods agree)
The price implies growth of 7.54% per year; the company grows at 0.43%.
Net margin 21.2%, ROE 12.2%.
Net margin
21.24%
Exceptional
Sector 6.32%|S&P 13.40%
Gross margin
—
Return on equity (ROE)
12.16%
Fair
Sector 12.03%|S&P 17.06%
Return on invested capital (ROIC)
9.47%
Free cash flow margin (FCF)
15.61%
Profit-to-cash conversion (FCF conversion)
0.74x
Margin stability
5.5 pts
Uneven
Revenue to net income
Growth
0.6/10Revenue down 31.0% over 1 year, -5.0% a year over 5, EPS 0.4% a year over 5.
Revenue (trailing 12 months)
16.6Md USD
Revenue growth (1y)
-30.99%
Declining
Revenue growth (3y)
-10.32%
Declining
EPS growth (1y)
-80.28%
Declining
EPS CAGR (5y)
0.43%
Fair
EPS revisions (3 months)
6.03%
Sharply revised up
Valuation
1.5/10P/E 18.6x, forward P/E 19.8x, PEG 43.06. The multiple sits in the 98th percentile of its own 5-year history.
P/E (TTM)
18.6x
Expensive
Sector 13.5x|S&P 23.6x
Forward P/E
19.8x
Expensive
EV / EBITDA
—
Sector 79.1x|S&P 15.5x
PEG
43.06
Very expensive
Sector 0.96|S&P 0.91
Fair value (reverse DCF)
118.91 USD
Fairly priced
P/E vs its own 5-year history
among the 2% highest valuations
At its historical high
Market cap
63.0Md USD
Not scored for a bank or an insurer: its solidity is measured by regulatory capital ratios, which we do not collect.
Net debt / EBITDA
—
Gearing (net debt / equity)
11.19%
Cash
5.6Md USD
Cash / market cap
8.93%
Cash / total debt
63.18%
Interest coverage
17.3x
Net debt
3.3Md USD
Equity
29.3Md USD
Closed daily candles, 2 years
Last close on November 10, 2026: 126.64 USD
- MM20122.36
- MM50117.90
- MM200116.45
- RSI 1467.3
Top panel: closed candles, 20, 50 and 200-day moving averages, with volume in grey. Bottom panel: 14-day RSI with dashed 30 and 70 levels.
200-day average slope, 1 month
+1.13%
200-day average slope, 3 months
+2.19%
50-day average slope, 1 month
+0.62%
Bullish RSI divergence
No
20-day volatility
1.15 % per day
Volatility change
+5.84%
Forecasts by fiscal year
| Fiscal year | EPS | Normalised EPS | Revenue | EBITDA | Net income |
|---|---|---|---|---|---|
| 2026 | 6.44 (5) | 7.46 (14) | 17 010 (4) | — | 3 242 (5) |
| 2027 | 7.80 (5) | 7.68 (15) | 17 180 (6) | — | 3 738 (5) |
Amounts in millions of USD, EPS in USD per share. In brackets, the number of analysts. Consensus as of November 11, 2026.
Same sub-industry: 81 companies behind the medians.
| # | Company | Code | Country | Overall / 10 | Fundamentals / 10 | Mkt cap | P/E | Net margin | Revenue growth | ROIC | Net debt / EBITDA | FCF yield | 1-year perf. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | MET | 7.2 | 7.2 | 64.7Md USD | 13.4x | 6.2 % | 19.4 % | — | — | — | 33.0 % | ||
| 2 | 2628 | 7.1 | 8.8 | 132Md USD | 2.4x | 41.3 % | 36.2 % | — | — | — | -22.3 % | ||
| 3 | 601318 | 6.7 | 7.3 | 136Md USD | — | — | 6.5 % | — | — | — | -10.3 % | ||
| 4 | 1299 | 6.2 | 5.7 | 105Md USD | 13.3x | 23.2 % | 10.0 % | — | — | — | -4.8 % | ||
| 5 | LICI | 6.2 | 6.1 | 53.9Md USD | 8.2x | 6.1 % | 9.8 % | — | — | — | -10.3 % | ||
| 6 | MFC | 5.8 | 4.7 | 72.8Md USD | 18.1x | 10.3 % | -31.3 % | — | — | — | 35.3 % | ||
| 7 | GWO | 5.7 | 4.8 | 59.1Md USD | 19.6x | 11.4 % | -67.1 % | — | — | — | 59.3 % | ||
| 8 | 2881 | 5.5 | 4.7 | 65.1Md USD | 13.7x | 18.1 % | -2.8 % | — | — | — | 73.8 % | ||
| 9 | AFL | 4.2 | 3.8 | 63.0Md USD | 18.6x | 21.2 % | -31.0 % | — | — | — | 11.9 % |
